PUCCI, Ida
 Distribuzione geografica
Continente #
NA - Nord America 7.930
EU - Europa 4.598
AS - Asia 3.645
SA - Sud America 606
Continente sconosciuto - Info sul continente non disponibili 234
AF - Africa 142
OC - Oceania 1
Totale 17.156
Nazione #
US - Stati Uniti d'America 7.713
SG - Singapore 1.216
RU - Federazione Russa 956
CN - Cina 933
FI - Finlandia 790
UA - Ucraina 626
IT - Italia 600
BR - Brasile 432
DE - Germania 426
HK - Hong Kong 370
VN - Vietnam 363
PL - Polonia 248
IE - Irlanda 235
GB - Regno Unito 223
FR - Francia 174
JP - Giappone 155
SE - Svezia 121
KR - Corea 103
BD - Bangladesh 97
IN - India 93
CA - Canada 79
MX - Messico 57
CO - Colombia 47
IQ - Iraq 45
CI - Costa d'Avorio 44
RO - Romania 43
EC - Ecuador 40
BE - Belgio 38
NL - Olanda 36
TR - Turchia 36
AR - Argentina 34
PK - Pakistan 34
ID - Indonesia 28
UZ - Uzbekistan 28
ZA - Sudafrica 28
CR - Costa Rica 21
VE - Venezuela 21
KE - Kenya 19
ES - Italia 17
JM - Giamaica 16
IR - Iran 15
PH - Filippine 14
NP - Nepal 13
CL - Cile 12
MY - Malesia 12
EG - Egitto 11
JO - Giordania 11
AT - Austria 10
CH - Svizzera 10
EE - Estonia 10
MA - Marocco 10
AE - Emirati Arabi Uniti 9
ET - Etiopia 9
NI - Nicaragua 9
SA - Arabia Saudita 9
TW - Taiwan 8
UY - Uruguay 8
BH - Bahrain 7
AZ - Azerbaigian 6
GR - Grecia 6
KZ - Kazakistan 6
LT - Lituania 6
PY - Paraguay 6
TT - Trinidad e Tobago 6
CZ - Repubblica Ceca 5
GT - Guatemala 5
HN - Honduras 5
LB - Libano 5
NG - Nigeria 5
TN - Tunisia 5
AL - Albania 4
BB - Barbados 4
BG - Bulgaria 4
GE - Georgia 4
PR - Porto Rico 4
PS - Palestinian Territory 4
SY - Repubblica araba siriana 4
BO - Bolivia 3
BZ - Belize 3
DZ - Algeria 3
EU - Europa 3
IL - Israele 3
LK - Sri Lanka 3
MD - Moldavia 3
PA - Panama 3
TH - Thailandia 3
GA - Gabon 2
HU - Ungheria 2
KW - Kuwait 2
MM - Myanmar 2
OM - Oman 2
PE - Perù 2
TG - Togo 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
BS - Bahamas 1
BY - Bielorussia 1
CG - Congo 1
DK - Danimarca 1
GY - Guiana 1
Totale 16.915
Città #
Ashburn 982
Singapore 787
San Jose 628
Ann Arbor 365
Jacksonville 357
Hong Kong 355
Woodbridge 328
Chandler 282
Fairfield 275
Wilmington 237
Dublin 232
Zgierz 212
Houston 209
Medford 175
Dallas 168
Beijing 167
Moscow 157
Tokyo 149
Des Moines 144
Santa Clara 143
Council Bluffs 139
Frankfurt am Main 136
Nanjing 131
Ho Chi Minh City 119
Los Angeles 114
Princeton 109
Seattle 103
Tulsa 93
Lauterbourg 87
Cambridge 85
New York 85
Hanoi 84
The Dalles 79
Hefei 76
Boardman 73
Buffalo 70
Palermo 66
Dearborn 65
Chicago 63
Helsinki 60
São Paulo 54
Nanchang 46
Abidjan 44
Venice 42
Milan 40
Brussels 38
Hebei 33
Shenyang 32
Tianjin 32
Ludwigshafen am Rhein 30
London 27
Seongnam 27
Changsha 26
Jinan 26
San Diego 25
Columbus 23
Da Nang 23
Jiaxing 23
Munich 23
Warsaw 23
Amsterdam 21
Atlanta 21
Tashkent 21
Verona 21
Philadelphia 20
Denver 19
Phoenix 19
Bogotá 18
Haiphong 18
Montreal 18
Seoul 18
Baghdad 17
City of London 17
Nairobi 17
Orem 17
Redondo Beach 17
Altamura 16
Johannesburg 16
Mexico City 16
Rome 16
Saint Petersburg 16
Toronto 16
Brooklyn 15
Cardiff 14
Chennai 14
Miami 14
Quito 14
San José 14
Zhengzhou 14
Turku 13
Kingston 12
Lawrence 12
Orange 12
Auburn Hills 11
Boston 11
Hangzhou 11
Kumar 11
Ningbo 11
San Francisco 11
Berlin 10
Totale 9.445
Nome #
Effetti indotti da fattori diffusibili fibroblastici sull'espressione proteica di cellule di carcinoma mammario. 404
In Vitro Phenotypic, Genomic and Proteomic Characterization of a Cytokine-Resistant Murine β-TC3 Cell Line 311
Multiple changes induced by fibroblasts on breast cancer cells. 298
Fibroblast’s role in breast cancer: a proteomic approach 253
Anti-oncogenic role of decorin: identification of new markers. 248
Large-scale proteomic identification of S100 proteins in breast cancer tissues. 236
Differential proteomic and phenotypic behaviour of papillary and anaplastic thyroid cell lines. 233
Retrospective Proteomic Screening of 100 Breast Cancer Tissues 232
CIRCULATING AND TISSUE FORMS OF MMP2 AND MMP9 IN BREAST CANCER PROGRESSION 228
A combined determination of circulating gelatinases and inflammatory markers in breast cancer patients during therapeutic treatment 227
COMPARATIVE PROTEOMIC PROFILING OF NORMAL AND BREAST CANCER CELLS UNDER HYPOXIC CONDITIONS 225
Breast cancer proteomics: from research to clinical applications. 215
Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera 213
Decorin Transfection induces proteomic and phenotypic modulation in breast cancer cells 8701-BC 209
DIFFERENTIAL PROTEOMIC ANALYSIS OF THYROID CARCINOMA CELL LlNES 205
Proteomic Analysis of Protein Components in Periodontal Ligament Fibroblasts 201
Cytoskeleton and Proteomic Changes Induced by Fibroblasts on Breast Cancer Cells 197
Proteo-genomic modulations induced on breast cancer cells by endothelial cells 197
Effects of endothelial cells on breast cancer cells in a co-culture system. 195
Comparative Proteomic and immunohistochemistry analyses to study alphaenolase/MBP-1 isoforms expression in breast cancer 190
Differential protein expression in cytokine-sensitive and -resistant pancreatic beta cell lines 188
Circulating levels of Matrix Metalloproteinases (MMP-2 and MMP-9), CRP and IL-6 during therapeutic treatment of patients with breast cancer 187
Comparative proteomics of breast cancer surgical tissues 185
Comparative detection of matrix metalloproteinase-2 and -9, interleukin-6 and c-reactive protein in breast cancer serum of patients during neoadjuvant chemotherapy 182
S-100 calcium binding proteins as potential markers for breast cancer metastasis. 181
Fibroblasts enhance proliferation and invasion of Breast Cancer Cells (8701-BC) 178
Genomic and proteomic profiling of decorin transfected breast cancer cells. 177
New insight on genomic and proteomic profiling of decorin-transfected breast cancer cells. 173
Endothelial cells and normal breast epithelial cells empower invasion of breast carcinoma cells by CXCR-4-dependent up-regulation of urokinase-type plasminogen activator receptor (uPAR, CD87) expression. 173
Clinicopathological correlations of MMP-2 and MMP-9 in breast cancer 172
Analysis of Trastuzumab effects in breast cancer cells in vitro 172
Differential proteomics of thyroid carcinoma cell lines 172
Carboplatin in combination with raltitrexed in recurrent and metastatic head and neck squamous cell carcinoma: A multicentre phase II study of the Gruppo Oncologico Dell'Italia Meridionale (G.O.I.M.) 171
Two-Dimensional Electrophoresis Analysis of Proteins Extracted From Leaves of Homozygous and Heterozygous Citrus 170
Herceptin-resistance in breast cancer cells: a proteomic study. 169
Correlation between MMPS and proteomic profiles of breast cancer tissues 167
Evaluation of cellular response of breast cancer cells grown on distinctive collagen substrates 167
Proteomic profling of B-cell chronic lymphocytic leukemia 166
Matrix metalloproteases monitoring during neoadjuvant breast cancer therapy. An ongoing study. 164
Proteomic profiling of B-cell chronic lymphocytic leukemia. A pilot study. 162
Multiple effects induced by herceptin® on 8701-BC breast cancer cells 162
Proteomic and genomic modulations of breast cancer cells co-cultured with endothelial cells. 160
Gene ontology-based annotation and comparative analysis of proteins extracted from proteomics of 100 breast cancer patients. 160
Ectopic decorin induces proteomic and phenotypic modulation of breast cancer cells. 159
Decorin transfection in breast cancer cells (8701-BC) induces proteomic modulation, cytoskeleton reorganization and inhibits matrix proteases 157
Proteomic analysis of extracellular vesicles shed in vitro by MDA MB 231 breast carcinoma cells 157
Proteomic modulation of neoplastic cells by extracellular matrix components 156
Ectopic decorin induces proteomic and phenotypic modulation of breast cells. 156
Analisi di cluster proteomici per l'identificazione di sottopopolazioni di pazienti con carcinoma mammario 156
Differential proteomic and phenotypic behavior of papillary and anaplastic thyroid carcinoma cell lines: an updated study 155
A PROTEOMIC CLUSTER FOR OSTEOTROPIC BREAST CANCER CELLS 153
Analisi comparativa tra linee cellulari di carcinoma tiroideo papillare ed anaplastico 153
AUTOANTIBODIES IDENTIFICATION IN BREAST CANCER SERA BY PROTEOMIC APPROACH 151
Levels of circulating gelatinases and proteomic correlations in breast cancer patients. 150
Fibroblast’s influence on breast cancer cells. 148
Effects of fibroblast diffusible factors on proteomic modulation of breast cancer cells. 147
Ectopic decorin induces proteomic and cytoskeleton modulation of breast cancer cells 146
Involvement of gelatinases in breast cancer: correlation with clinical parameters and 2D-IPG applications. 146
Studio dell'interattoma di PAR-6 in cellule di carcinoma mammario 8701-BC 146
Proteomic Detection of Breast-Cancer Subpopulations. 146
Modulazione del proteoma indotta in cellule di carcinoma mammario da decorina ectopica 145
Different collagen substrates induce the expression of alternative forms of keratins and vimentin in breast cancer cells. 145
Effects of Hypoxia on 8701-BC cancer cells. 145
Cross-talk between fibroblast and breast cancer cells: a proteomic study 144
PROTEOMIC EFFECTS INDUCED BY MICROENVIRONMENT COMPONENTS ON 8701-BC BREAST CANCER CELLS: AN UPDATED REPORT 144
LARGE-SCALE COMPARATIVE PROTEOMICS OF BREAST CANCER SURGICAL TISSUES 144
Occurrence of S100A7 in a large sample-set of breast cancer tissues 141
La post-genomica in Oncologia: prospettive e problematiche. Analisi proteomica 140
Cross-talk between breast cancer cells and fibroblasts in coculture system. 139
S100S PROTEIN EXPRESSION IN A LARGE SAMPLE-SET OF BREAST CANCER TISSUES 138
Proteomic detection of S100 proteins in breastcancer tissues 138
Cytoskeleton modulation in breast cancer cells induced by stromal microenvironment. 137
Herceptin-resistance in breast cancer cells: a proteomic approach 137
Proteomics and proteomic modulations of breast cancer cells 136
Zymographic detection of MMP-2 and MMP-9 in breast cancer sera patients during chemotherapy. 136
Herceptin Resistance and Malignant Potential of Cancer Cells. 136
PROTEOMIC MODULATION IN BREAST CANCER CELLS INDUCED BY MICROENVIRONMENT COMPONENTS 133
Proteomic modulation induced in fibroblasts by breast cancer cells (8701‐BC)paracrine factors. 133
EFFETTI DEL TRASTUZUMAB SUL PROTEOMA DI CELLULE DI CARCINOMA MAMMARIO OVER-ESPRIMENTI HER-2 133
IDENTIFICATION OF TYPE V COLLAGEN-BINDING PROTEINS IN 8701-BC BREAST CANCER CELLS 133
The fibroblasts: co-actors in cancer. 132
Large-scale comparative proteomics of breast surgical tissues 132
Identificazione di forme multiple di cheratine 8, 18 e vimentina espresse da cellule di carcinoma mammario coltivate su differenti substrati collagene 130
Decorin transfection induces proteomic modulation and cytoskeletal rioganization in breast cancer cells (8701-BC) 128
Multi-omics analysis of epithelial-to mesenchymal transition mediators in breast cancer 125
Zymographic detection of matrix proteases in breast cancer biopsies by mono- and two-dimensional electrophoresis 125
Hypoxia influence on differential gene expression of 8701-BC cancer cells. 122
LARGE-SCALE SCREENING OF MATRIX METALLOPROTEINASES IN BREAST CANCER PATIENTS AND CLINICAL-MOLECULAR CORRELATIONS 119
Identification of multiple forms of keratins expressed by brest cancer cells coltured on different collagen substrates. 118
Proteomic profile of hypoxic breast cancer cells 118
Proteomic profiling of Trastuzumab (Herceptin(R))-sensitive and -resistant SKBR-3 breast cancer cells. 118
Modulation of neoplastic phenotype by Extracellular Matrix components. 117
Fibroblast-derived factors modulate breast cancer cell proteomics. 114
Permissive and restrictive influences from breast cancer stroma 114
Proteomic modulation of breast cancer cells (8701-BC) cocultured with normal human fibroblasts. 113
Extraction of Proteins From Leaves of Homozygous and Heterozygous Citrus for Two-Dimensional Electrophoresis Analysis. 113
MMP-2, MMP-9 and MMP-14 in breast cancer: clinicopathological correlations. 112
The cytoskeletal network in fibroblasts cultured from PXE patients 109
The challenge of tumor microenvironment 109
Identification of multiple forms of keratins expressed by breast cancer cells coltured on different collagen substrates. 108
Totale 16.410
Categoria #
all - tutte 52.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022644 0 0 0 11 27 26 18 50 102 157 29 224
2022/20231.030 159 67 13 92 129 196 104 59 153 13 37 8
2023/2024635 30 106 31 100 80 115 53 23 0 12 6 79
2024/20251.569 29 107 84 122 76 31 116 74 122 163 264 381
2025/20266.365 465 160 361 453 609 762 707 661 466 1.036 439 246
2026/20271.754 268 253 1.021 212 0 0 0 0 0 0 0 0
Totale 17.156